421 related articles for article (PubMed ID: 25427584)
21. Side population in MDA-MB-231 human breast cancer cells exhibits cancer stem cell-like properties without higher bone-metastatic potential.
Hiraga T; Ito S; Nakamura H
Oncol Rep; 2011 Jan; 25(1):289-96. PubMed ID: 21109989
[TBL] [Abstract][Full Text] [Related]
22. Drug Transporter-Mediated Protection of Cancer Stem Cells From Ionophore Antibiotics.
Boesch M; Zeimet AG; Rumpold H; Gastl G; Sopper S; Wolf D
Stem Cells Transl Med; 2015 Sep; 4(9):1028-32. PubMed ID: 26136502
[TBL] [Abstract][Full Text] [Related]
23. CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics.
Feng BH; Liu AG; Gu WG; Deng L; Cheng XG; Tong TJ; Zhang HZ
Oncol Rep; 2013 Aug; 30(2):815-23. PubMed ID: 23708735
[TBL] [Abstract][Full Text] [Related]
24. Characterization of cancer stem-like cells derived from a side population of a human gallbladder carcinoma cell line, SGC-996.
Li XX; Wang J; Wang HL; Wang W; Yin XB; Li QW; Chen YY; Yi J
Biochem Biophys Res Commun; 2012 Mar; 419(4):728-34. PubMed ID: 22387537
[TBL] [Abstract][Full Text] [Related]
25. ABCG2 is a potential marker of tumor-initiating cells in breast cancer.
Sicchieri RD; da Silveira WA; Mandarano LR; de Oliveira TM; Carrara HH; Muglia VF; de Andrade JM; Tiezzi DG
Tumour Biol; 2015 Dec; 36(12):9233-43. PubMed ID: 26091795
[TBL] [Abstract][Full Text] [Related]
26. Stem cell-like side populations in esophageal cancer: a source of chemotherapy resistance and metastases.
Zhao Y; Bao Q; Schwarz B; Zhao L; Mysliwietz J; Ellwart J; Renner A; Hirner H; Niess H; Camaj P; Angele M; Gros S; Izbicki J; Jauch KW; Nelson PJ; Bruns CJ
Stem Cells Dev; 2014 Jan; 23(2):180-92. PubMed ID: 24021093
[TBL] [Abstract][Full Text] [Related]
27. Side population cells and drug resistance in breast cancer.
Wang M; Wang Y; Zhong J
Mol Med Rep; 2015 Jun; 11(6):4297-302. PubMed ID: 25647733
[TBL] [Abstract][Full Text] [Related]
28. Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1.
Liu T; Xu F; Du X; Lai D; Liu T; Zhao Y; Huang Q; Jiang L; Huang W; Cheng W; Liu Z
Mol Cell Biochem; 2010 Jul; 340(1-2):265-73. PubMed ID: 20224986
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of Wnt signaling pathway decreases chemotherapy-resistant side-population colon cancer cells.
Chikazawa N; Tanaka H; Tasaka T; Nakamura M; Tanaka M; Onishi H; Katano M
Anticancer Res; 2010 Jun; 30(6):2041-8. PubMed ID: 20651349
[TBL] [Abstract][Full Text] [Related]
30. Targeting BCRP/ABCG2 by RNA interference enhances the chemotherapy sensitivity of human colon cancer side population cells.
Hu J; Li J; Yue X; Wang JC; Wang JF; Liu JZ; Kong DL
J Huazhong Univ Sci Technolog Med Sci; 2017 Apr; 37(2):231-236. PubMed ID: 28397046
[TBL] [Abstract][Full Text] [Related]
31. Increased JNK1 signaling pathway is responsible for ABCG2-mediated multidrug resistance in human colon cancer.
Zhu MM; Tong JL; Xu Q; Nie F; Xu XT; Xiao SD; Ran ZH
PLoS One; 2012; 7(8):e41763. PubMed ID: 22870247
[TBL] [Abstract][Full Text] [Related]
32. ABCG2 expression is correlated neither to side population nor to hematopoietic progenitor function in human umbilical cord blood.
Alt R; Wilhelm F; Pelz-Ackermann O; Egger D; Niederwieser D; Cross M
Exp Hematol; 2009 Feb; 37(2):294-301. PubMed ID: 19101070
[TBL] [Abstract][Full Text] [Related]
33. Characterization of a side population of astrocytoma cells in response to temozolomide.
Chua C; Zaiden N; Chong KH; See SJ; Wong MC; Ang BT; Tang C
J Neurosurg; 2008 Nov; 109(5):856-66. PubMed ID: 18976075
[TBL] [Abstract][Full Text] [Related]
34. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.
Hu J; Zhang X; Wang F; Wang X; Yang K; Xu M; To KK; Li Q; Fu L
Oncotarget; 2015 Dec; 6(42):44643-59. PubMed ID: 26556876
[TBL] [Abstract][Full Text] [Related]
35. Establishment of pancreatic cancer stem cells by flow cytometry and their biological characteristics.
Li D; Su D; Xue L; Liu Y; Pang W
Int J Clin Exp Pathol; 2015; 8(9):11218-23. PubMed ID: 26617845
[TBL] [Abstract][Full Text] [Related]
36. Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma.
Yang JP; Liu Y; Zhong W; Yu D; Wen LJ; Jin CS
Chin Med J (Engl); 2011 Apr; 124(7):1055-60. PubMed ID: 21542968
[TBL] [Abstract][Full Text] [Related]
37. Developing multidrug-resistant cells and exploring correlation between BCRP/ABCG2 over-expression and DNA methyltransferase.
Ji N; Yuan J; Liu J; Tian S
Acta Biochim Biophys Sin (Shanghai); 2010 Dec; 42(12):854-62. PubMed ID: 21106767
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.
Cheng W; Liu T; Wan X; Gao Y; Wang H
FEBS J; 2012 Jun; 279(11):2047-59. PubMed ID: 22498306
[TBL] [Abstract][Full Text] [Related]
39. MAGE-A3 is highly expressed in a cancer stem cell-like side population of bladder cancer cells.
Yin B; Zeng Y; Liu G; Wang X; Wang P; Song Y
Int J Clin Exp Pathol; 2014; 7(6):2934-41. PubMed ID: 25031712
[TBL] [Abstract][Full Text] [Related]
40. FaDu cell characteristics induced by multidrug resistance.
Ma J; Lu S; Yu L; Tian J; Li J; Wang H; Xu W
Oncol Rep; 2011 Nov; 26(5):1189-95. PubMed ID: 21833476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
